Skip to main content
. Author manuscript; available in PMC: 2018 Jan 10.
Published in final edited form as: Circulation. 2017 Jan 10;135(2):180–195. doi: 10.1161/CIRCULATIONAHA.116.022622

Figure 5. Balancing Benefits and Harms of Antihyperglycemic Treatment.

Figure 5

Net lifetime quality-adjusted life years gained or lost by a treatment that leads to a 1% reduction in the hemoglobin A1C level (from 8.5% to 7.5%) across four age groups and different views of the burden of treatment (disutility value for treatment ranging from 0 to 0.05). This figure was reproduced with permission from JAMA Internal Medicine, 2014, 174(8), 1227–1234.40 Copyright ©2014, American Medical Association.